H15_HUMAN - dbPTM
H15_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H15_HUMAN
UniProt AC P16401
Protein Name Histone H1.5
Gene Name HIST1H1B
Organism Homo sapiens (Human).
Sequence Length 226
Subcellular Localization Nucleus. Chromosome. According to PubMed:15911621 more commonly found in heterochromatin. According to PubMed:10997781 associates with actively transcribed chromatin and not heterochromatin.
Protein Description Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity)..
Protein Sequence MSETAPAETATPAPVEKSPAKKKATKKAAGAGAAKRKATGPPVSELITKAVAASKERNGLSLAALKKALAAGGYDVEKNNSRIKLGLKSLVSKGTLVQTKGTGASGSFKLNKKAASGEAKPKAKKAGAAKAKKPAGATPKKAKKAAGAKKAVKKTPKKAKKPAAAGVKKVAKSPKKAKAAAKPKKATKSPAKPKAVKPKAAKPKAAKPKAAKPKAAKAKKAAAKKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSETAPAET
------CCCCCCCCC
43.5919691289
2Phosphorylation------MSETAPAET
------CCCCCCCCC
43.5929255136
4Phosphorylation----MSETAPAETAT
----CCCCCCCCCCC
30.5429255136
9PhosphorylationSETAPAETATPAPVE
CCCCCCCCCCCCCCC
37.6329255136
11PhosphorylationTAPAETATPAPVEKS
CCCCCCCCCCCCCCC
27.6629255136
17AcetylationATPAPVEKSPAKKKA
CCCCCCCCCHHHHHH
63.0717043054
17MalonylationATPAPVEKSPAKKKA
CCCCCCCCCHHHHHH
63.0726320211
17UbiquitinationATPAPVEKSPAKKKA
CCCCCCCCCHHHHHH
63.0733845483
18PhosphorylationTPAPVEKSPAKKKAT
CCCCCCCCHHHHHHH
19.3129255136
21UbiquitinationPVEKSPAKKKATKKA
CCCCCHHHHHHHHHH
59.1822505724
22UbiquitinationVEKSPAKKKATKKAA
CCCCHHHHHHHHHHH
50.15-
23AcetylationEKSPAKKKATKKAAG
CCCHHHHHHHHHHHC
61.6620687029
25PhosphorylationSPAKKKATKKAAGAG
CHHHHHHHHHHHCCH
41.7926074081
26AcetylationPAKKKATKKAAGAGA
HHHHHHHHHHHCCHH
45.3215469825
26MethylationPAKKKATKKAAGAGA
HHHHHHHHHHHCCHH
45.3215469825
27LactylationAKKKATKKAAGAGAA
HHHHHHHHHHCCHHH
38.8331645732
27MethylationAKKKATKKAAGAGAA
HHHHHHHHHHCCHHH
38.8319552482
352-HydroxyisobutyrylationAAGAGAAKRKATGPP
HHCCHHHHHHCCCCC
54.63-
35AcetylationAAGAGAAKRKATGPP
HHCCHHHHHHCCCCC
54.637664325
35UbiquitinationAAGAGAAKRKATGPP
HHCCHHHHHHCCCCC
54.6322817900
37"N6,N6-dimethyllysine"GAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.98-
37AcetylationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.9826051181
37LactylationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.9831645732
37MalonylationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.9826320211
37MethylationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.98-
37OtherGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.98-
37SuccinylationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.98-
37UbiquitinationGAGAAKRKATGPPVS
CCHHHHHHCCCCCHH
49.9822817900
39PhosphorylationGAAKRKATGPPVSEL
HHHHHHCCCCCHHHH
53.9423911959
44PhosphorylationKATGPPVSELITKAV
HCCCCCHHHHHHHHH
32.2423911959
48PhosphorylationPPVSELITKAVAASK
CCHHHHHHHHHHHHH
26.1026074081
492-HydroxyisobutyrylationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.59-
49AcetylationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5925953088
49UbiquitinationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5923000965
54PhosphorylationITKAVAASKERNGLS
HHHHHHHHHHHCCCC
25.8826546556
55AcetylationTKAVAASKERNGLSL
HHHHHHHHHHCCCCH
56.847296747
55OtherTKAVAASKERNGLSL
HHHHHHHHHHCCCCH
56.84-
55UbiquitinationTKAVAASKERNGLSL
HHHHHHHHHHCCCCH
56.8423000965
57CitrullinationAVAASKERNGLSLAA
HHHHHHHHCCCCHHH
46.37-
57CitrullinationAVAASKERNGLSLAA
HHHHHHHHCCCCHHH
46.37-
61PhosphorylationSKERNGLSLAALKKA
HHHHCCCCHHHHHHH
19.8419691289
662-HydroxyisobutyrylationGLSLAALKKALAAGG
CCCHHHHHHHHHCCC
31.13-
66AcetylationGLSLAALKKALAAGG
CCCHHHHHHHHHCCC
31.1325953088
66SuccinylationGLSLAALKKALAAGG
CCCHHHHHHHHHCCC
31.1323954790
66UbiquitinationGLSLAALKKALAAGG
CCCHHHHHHHHHCCC
31.1322817900
672-HydroxyisobutyrylationLSLAALKKALAAGGY
CCHHHHHHHHHCCCC
49.86-
67AcetylationLSLAALKKALAAGGY
CCHHHHHHHHHCCCC
49.8626051181
67OtherLSLAALKKALAAGGY
CCHHHHHHHHHCCCC
49.86-
67UbiquitinationLSLAALKKALAAGGY
CCHHHHHHHHHCCCC
49.8621906983
74NitrationKALAAGGYDVEKNNS
HHHHCCCCCCCCCCC
18.85-
74PhosphorylationKALAAGGYDVEKNNS
HHHHCCCCCCCCCCC
18.8522817900
782-HydroxyisobutyrylationAGGYDVEKNNSRIKL
CCCCCCCCCCCCEEE
62.37-
78AcetylationAGGYDVEKNNSRIKL
CCCCCCCCCCCCEEE
62.3723954790
78MalonylationAGGYDVEKNNSRIKL
CCCCCCCCCCCCEEE
62.3726320211
78UbiquitinationAGGYDVEKNNSRIKL
CCCCCCCCCCCCEEE
62.3721906983
81PhosphorylationYDVEKNNSRIKLGLK
CCCCCCCCCEEEHHH
44.7928634120
84UbiquitinationEKNNSRIKLGLKSLV
CCCCCCEEEHHHHHH
35.0823000965
88AcetylationSRIKLGLKSLVSKGT
CCEEEHHHHHHHCCC
39.6917043054
88OtherSRIKLGLKSLVSKGT
CCEEEHHHHHHHCCC
39.69-
88UbiquitinationSRIKLGLKSLVSKGT
CCEEEHHHHHHHCCC
39.6923000965
89PhosphorylationRIKLGLKSLVSKGTL
CEEEHHHHHHHCCCE
38.7620860994
92PhosphorylationLGLKSLVSKGTLVQT
EHHHHHHHCCCEEEE
30.5717877366
93AcetylationGLKSLVSKGTLVQTK
HHHHHHHCCCEEEEC
48.737692537
93OtherGLKSLVSKGTLVQTK
HHHHHHHCCCEEEEC
48.73-
93UbiquitinationGLKSLVSKGTLVQTK
HHHHHHHCCCEEEEC
48.7323000965
95PhosphorylationKSLVSKGTLVQTKGT
HHHHHCCCEEEECCC
27.7417877366
99PhosphorylationSKGTLVQTKGTGASG
HCCCEEEECCCCCCC
24.7828111955
100SuccinylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.07-
100UbiquitinationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0723000965
102PhosphorylationTLVQTKGTGASGSFK
CEEEECCCCCCCCEE
31.0026657352
105PhosphorylationQTKGTGASGSFKLNK
EECCCCCCCCEECCC
35.9925159151
107PhosphorylationKGTGASGSFKLNKKA
CCCCCCCCEECCCCC
19.4023401153
109AcetylationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5022648155
109OtherTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.50-
109UbiquitinationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5027667366
112UbiquitinationSGSFKLNKKAASGEA
CCCEECCCCCCCCCC
54.9822817900
113UbiquitinationGSFKLNKKAASGEAK
CCEECCCCCCCCCCC
48.3821906983
116PhosphorylationKLNKKAASGEAKPKA
ECCCCCCCCCCCHHH
41.8626657352
120UbiquitinationKAASGEAKPKAKKAG
CCCCCCCCHHHHHHC
42.6321906983
122UbiquitinationASGEAKPKAKKAGAA
CCCCCCHHHHHHCHH
72.6129967540
132AcetylationKAGAAKAKKPAGATP
HHCHHHCCCCCCCCH
59.5930584587
132UbiquitinationKAGAAKAKKPAGATP
HHCHHHCCCCCCCCH
59.5925015289
133AcetylationAGAAKAKKPAGATPK
HCHHHCCCCCCCCHH
44.9830584593
133UbiquitinationAGAAKAKKPAGATPK
HCHHHCCCCCCCCHH
44.9833845483
138PhosphorylationAKKPAGATPKKAKKA
CCCCCCCCHHHHHHH
34.4222167270
140AcetylationKPAGATPKKAKKAAG
CCCCCCHHHHHHHHC
62.097369411
140UbiquitinationKPAGATPKKAKKAAG
CCCCCCHHHHHHHHC
62.0925015289
141UbiquitinationPAGATPKKAKKAAGA
CCCCCHHHHHHHHCC
67.6425015289
143AcetylationGATPKKAKKAAGAKK
CCCHHHHHHHHCCHH
52.3924431093
144AcetylationATPKKAKKAAGAKKA
CCHHHHHHHHCCHHH
48.6124431101
149AcetylationAKKAAGAKKAVKKTP
HHHHHCCHHHHHCCC
40.1124431109
155PhosphorylationAKKAVKKTPKKAKKP
CHHHHHCCCHHCCCC
34.3216377619
157UbiquitinationKAVKKTPKKAKKPAA
HHHHCCCHHCCCCHH
71.2722817900
158AcetylationAVKKTPKKAKKPAAA
HHHCCCHHCCCCHHH
67.6417043054
158UbiquitinationAVKKTPKKAKKPAAA
HHHCCCHHCCCCHHH
67.6422817900
160AcetylationKKTPKKAKKPAAAGV
HCCCHHCCCCHHHCH
69.0725953088
160UbiquitinationKKTPKKAKKPAAAGV
HCCCHHCCCCHHHCH
69.0722817900
161UbiquitinationKTPKKAKKPAAAGVK
CCCHHCCCCHHHCHH
44.7621906983
1682-HydroxyisobutyrylationKPAAAGVKKVAKSPK
CCHHHCHHHHHCCHH
40.38-
168AcetylationKPAAAGVKKVAKSPK
CCHHHCHHHHHCCHH
40.3819608861
168LactylationKPAAAGVKKVAKSPK
CCHHHCHHHHHCCHH
40.3831645732
168UbiquitinationKPAAAGVKKVAKSPK
CCHHHCHHHHHCCHH
40.3822817900
169MethylationPAAAGVKKVAKSPKK
CHHHCHHHHHCCHHH
45.0517043054
169UbiquitinationPAAAGVKKVAKSPKK
CHHHCHHHHHCCHHH
45.0522817900
172UbiquitinationAGVKKVAKSPKKAKA
HCHHHHHCCHHHHHH
70.9922817900
173PhosphorylationGVKKVAKSPKKAKAA
CHHHHHCCHHHHHHH
32.0130278072
185UbiquitinationKAAAKPKKATKSPAK
HHHHCCCCCCCCCCC
70.5725015289
187PhosphorylationAAKPKKATKSPAKPK
HHCCCCCCCCCCCCC
40.7228176443
188LactylationAKPKKATKSPAKPKA
HCCCCCCCCCCCCCC
60.3431645732
188MethylationAKPKKATKSPAKPKA
HCCCCCCCCCCCCCC
60.34-
188UbiquitinationAKPKKATKSPAKPKA
HCCCCCCCCCCCCCC
60.3425015289
189PhosphorylationKPKKATKSPAKPKAV
CCCCCCCCCCCCCCC
26.2428176443
192UbiquitinationKATKSPAKPKAVKPK
CCCCCCCCCCCCCCC
50.8925015289
194UbiquitinationTKSPAKPKAVKPKAA
CCCCCCCCCCCCCCC
66.1725015289
197UbiquitinationPAKPKAVKPKAAKPK
CCCCCCCCCCCCCCC
45.7325015289
199AcetylationKPKAVKPKAAKPKAA
CCCCCCCCCCCCCCC
56.0819608861
199UbiquitinationKPKAVKPKAAKPKAA
CCCCCCCCCCCCCCC
56.0825015289
202AcetylationAVKPKAAKPKAAKPK
CCCCCCCCCCCCCCC
52.4919608861
202UbiquitinationAVKPKAAKPKAAKPK
CCCCCCCCCCCCCCC
52.4925015289
204AcetylationKPKAAKPKAAKPKAA
CCCCCCCCCCCCCCC
61.3419608861
204UbiquitinationKPKAAKPKAAKPKAA
CCCCCCCCCCCCCCC
61.3425015289
207UbiquitinationAAKPKAAKPKAAKPK
CCCCCCCCCCCCCHH
52.4925015289
209AcetylationKPKAAKPKAAKPKAA
CCCCCCCCCCCHHHH
61.34-
209UbiquitinationKPKAAKPKAAKPKAA
CCCCCCCCCCCHHHH
61.3425015289
212UbiquitinationAAKPKAAKPKAAKAK
CCCCCCCCHHHHHHH
52.4925015289
214UbiquitinationKPKAAKPKAAKAKKA
CCCCCCHHHHHHHHH
61.3425015289

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
11TPhosphorylationKinaseGSK3BP49841
PSP
11TPhosphorylationKinaseGSK3-Uniprot
-KUbiquitinationE3 ubiquitin ligaseHUWE1Q7Z6Z7
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
11TPhosphorylation

16377619
57RCitrullination

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H15_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FOXP3_HUMANFOXP3physical
21654845
CUL5_HUMANCUL5physical
22863883
CYHR1_HUMANCYHR1physical
22863883
NMI_HUMANNMIphysical
22863883
GLYM_HUMANSHMT2physical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H15_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-93; LYS-109; LYS-168 ANDLYS-209, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-11; SER-18 AND THR-39,AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-11; SER-18;THR-39; SER-44; THR-187 AND SER-189, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND MASSSPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4 AND SER-18, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-138, AND MASSSPECTROMETRY.

TOP